Ferric recalls
The FDA has published 4 recalls involving Ferric since 2018. The latest was reported on 2 Jun 2021. Most were for manufacturing (cgmp) deviations. Keryx Biopharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 75%Class III 1 25%
Why ferric is recalled
Companies
By year
All ferric recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Auryxia (ferric citrate) tablets 210 mg* recalled by Cardinal HealthAuryxia | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Auryxia (ferric citrate) tablets, 210 mg recalled by Akebia TherapeuticsAuryxia | Akebia Therapeutics | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Auryxia (ferric citrate) tablets 210 mg recalledAuryxia | Keryx Biopharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Auryxia (ferric citrate) tablets, 210 mg recalledAuryxia | Keryx Biopharmaceuticals | Other | Nationwide |
Should you stop taking Ferric?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.